Omega Fund Management

Omega Fund Management as of Sept. 30, 2021

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 26 positions in its portfolio as reported in the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Nuvation Bio Common Stock (NUVB) 31.5 $280M 28M 9.94
Replimune Group Common Stock (REPL) 16.3 $145M 4.9M 29.64
Kronos Bio Common Stock (KRON) 9.0 $80M 3.8M 20.96
Morphic Holding Common Stock (MORF) 8.4 $75M 1.3M 56.64
Imago Biosciences Common Stock 6.8 $61M 3.0M 20.03
Gossamer Bio Common Stock (GOSS) 4.7 $42M 3.3M 12.57
Ikena Oncology Common Stock (IKNA) 3.2 $28M 2.2M 12.62
Adagio Therapeutics Common Stock (IVVD) 3.0 $27M 633k 42.24
Alpine Immune Sciences Common Stock 2.4 $22M 2.0M 10.67
Sana Biotechnology Common Stock (SANA) 2.1 $19M 844k 22.52
Immunic Common Stock (IMUX) 1.8 $16M 1.8M 8.85
Arcutis Biothereapeutics Common Stock (ARQT) 1.7 $15M 624k 23.89
Spruce Biosciences Common Stock (SPRB) 1.5 $13M 2.2M 6.01
Paratek Pharmaceuticals Common Stock 1.4 $13M 2.6M 4.86
Icosavax Common Stock 1.4 $13M 426k 29.59
Syros Pharmaceuticals Common Stock 1.3 $11M 2.5M 4.47
Atea Pharmaceuticals Common Stock (AVIR) 0.6 $5.8M 165k 35.06
Checkmate Pharmaceuticals Common Stock 0.6 $5.3M 1.3M 3.97
Omega Alpha SPAC Common Stock 0.5 $4.9M 501k 9.73
Cidara Therapeutics Common Stock 0.5 $4.5M 2.0M 2.24
ObsEva SA Common Stock 0.3 $3.1M 999k 3.11
ESSA Pharma Common Stock (EPIX) 0.3 $2.6M 328k 8.00
Jounce Therapeutics Common Stock 0.2 $2.0M 276k 7.43
Immunocore Holdings Common Stock (IMCR) 0.2 $1.9M 52k 37.06
Trevi Therapeutics Common Stock (TRVI) 0.2 $1.8M 1.3M 1.40
FibroGen Common Stock (FGEN) 0.1 $1.1M 131k 8.80